Logo
x

Search category

Subscribe Now

Dystrophic Epidermolysis Bullosa (DEB)

Amyrt's AP103 Receives the US FDA's Orphan Drug designation for Dystrophic Epidermolysis Bullosa (DEB)

Amyrt's AP103 Receives the US FDA's Orphan Drug designation for Dystrophic Epidermolysis Bullosa (DEB)

  • December 28, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.